Immage Biotherapeutics Corp. is a biotechnology company, which develops novel immunotherapy biologics to treat various cancers. It develops, markets, and licenses its patented immunotherapy candidate for MAGE A. It encompasses vaccines, oncolytic viruses, adjuvants, and adoptive t-cell technologies. The company was founded by Anton Dormer and Mahesh Narayanan on June 21, 2012 and is headquartered in Bethesda, MD.
Company profile
Ticker
IMMG
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Epicure Charcoal, Inc.
SEC CIK
Corporate docs
Latest filings (excl ownership)
15-15D
Suspension of duty to report
22 Jun 17
10-Q
2017 Q2
Quarterly report
19 Apr 17
NT 10-Q
Notice of late quarterly filing
17 Apr 17
8-K
Other Events
28 Feb 17
10-Q
2017 Q1
Quarterly report
6 Jan 17
10-K
2016 FY
Annual report
8 Dec 16
NT 10-K
Notice of late annual filing
29 Nov 16
10-Q
2016 Q3
Quarterly report
15 Jul 16
10-Q
2016 Q2
Quarterly report
14 Apr 16
10-Q
2016 Q1
Quarterly report
19 Jan 16